| Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. | |
| | |
MedLine Citation:
|
PMID: 20840539 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND AND PURPOSE: To investigate whether diabetes affects either or both nitric oxide (NO)-mediated and endothelium-derived hyperpolarizing factor (EDHF)-type relaxation in endothelium-dependent relaxation of mesenteric arteries from streptozotocin-induced diabetic rats. EXPERIMENTAL APPROACH: Wire myography was employed to examine endothelial function of mesenteric arteries. Superoxide levels were measured by L-012 and lucigenin-enhanced chemiluminescence. Western blotting was used to quantify protein expression levels. KEY RESULTS: Superoxide levels were significantly increased in diabetic mesenteric arteries compared with normal arteries. Diabetes significantly reduced the sensitivity to the endothelium-dependent relaxant, acetylcholine (ACh) in mesenteric arteries. When the contribution of NO to relaxation was abolished by N-nitro-L-arginine (L-NNA) + a soluble guanylate cyclase inhibitor (ODQ), the sensitivity to ACh was significantly decreased in the diabetic arteries compared with normal arteries, indicating an impaired EDHF-type relaxation despite increased expression of intermediate- and small-conductance calcium-activated potassium channels. Conversely, when the contribution of EDHF was inhibited with TRAM-34 + apamin + iberiotoxin, maximum relaxations to ACh were significantly decreased in diabetic compared with normal arteries, suggesting that the contribution of NO was also impaired by diabetes. Basal levels of NO release, indicated by contraction to L-NNA, were also significantly decreased in diabetic arteries. Western blot analysis demonstrated that diabetic arteries had an increased expression of Nox2, decreased pSer⁴⁷³ Akt and a reduced proportion of endothelial NO synthase (eNOS) expressed as a dimer, indicating uncoupling. CONCLUSION AND IMPLICATIONS: The contribution of both NO and EDHF-type relaxations was impaired in diabetes and was caused by increased oxidative stress, decreased pSer⁴⁷³ Akt and/or eNOS uncoupling. |
| | |
Authors:
|
C H Leo; J L Hart; O L Woodman |
Related Documents
:
|
16982479 - Fractal dimension of the middle meningeal vessels: variation and evolution in homo erec... 7589879 - Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a me... 6175049 - Platelet aggregation and plasma levels of beta-thromboglobulin in diabetes mellitus. 14671039 - Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial ce... 1700209 - Augmented vascular relaxation to kt-362 in diabetic rat aorta: comparison to diltiazem. 21736289 - One-step electrochemical synthesis of ptni nanoparticle-graphene nanocomposites for non... 3958969 - Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipi... 22000639 - Infrared spectroscopic analysis of human interstitial fluid in vitro and in vivo using ... 10566809 - Effects of chromium supplementation on glucose tolerance in obese and nonobese cats. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: British journal of pharmacology Volume: 162 ISSN: 1476-5381 ISO Abbreviation: Br. J. Pharmacol. Publication Date: 2011 Jan |
Date Detail:
|
Created Date: 2010-12-15 Completed Date: 2011-06-29 Revised Date: 2012-01-02 |
Medline Journal Info:
|
Nlm Unique ID: 7502536 Medline TA: Br J Pharmacol Country: England |
Other Details:
|
Languages: eng Pagination: 365-77 Citation Subset: IM |
Copyright Information:
|
© 2010 The Authors. British Journal of Pharmacology © 2010 The British Pharmacological Society. |
Affiliation:
|
Health Innovation Research Institute, RMIT University, Bundoora, Victoria, Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Biological Factors / metabolism* Blood Glucose / analysis Body Weight Cyclooxygenase Inhibitors / pharmacology Diabetes Mellitus, Experimental / metabolism, physiopathology* Endothelium, Vascular / physiopathology* Hemoglobin A, Glycosylated / analysis Indomethacin / pharmacology Male Mesenteric Arteries / physiopathology* Nitric Oxide / metabolism*, pharmacology Oxidative Stress Rats Rats, Sprague-Dawley Small-Conductance Calcium-Activated Potassium Channels / metabolism Superoxides / metabolism Vasodilation* Vasodilator Agents / pharmacology |
| Chemical | |
Reg. No./Substance:
|
0/Biological Factors; 0/Blood Glucose; 0/Cyclooxygenase Inhibitors; 0/Hemoglobin A, Glycosylated; 0/Small-Conductance Calcium-Activated Potassium Channels; 0/Vasodilator Agents; 0/endothelium-dependent hyperpolarization factor; 0/hemoglobin A1c protein, human; 10102-43-9/Nitric Oxide; 11062-77-4/Superoxides; 53-86-1/Indomethacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and r...
Next Document: Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-?B p...